AT

Lichen Planus

Dermatology · Papulosquamous · lean revision notes

Lichen Planus

Lichen planus (LP) is a chronic, idiopathic, T-cell-mediated inflammatory dermatosis affecting the skin, mucous membranes, nails, and hair. It is the prototype of the papulosquamous group and a perennial NEET PG favourite because of its classic morphology (the "six Ps"), Wickham striae, hepatitis C link, the malignant potential of oral LP, and its many clinical variants.

Definition & classification

Lichen planus is defined as a cell-mediated immune reaction in which CD8+ cytotoxic T-lymphocytes attack basal keratinocytes that express an altered self-antigen, producing the histological hallmark of band-like lymphocytic infiltrate with basal cell degeneration. The word "lichen" reflects the flat, lichen-on-a-rock appearance of the papules.

Clinical (morphological) variants — high yield:

Variant Key feature Site / clue
Classic (papular) Violaceous, flat-topped, polygonal papules Flexor wrists, ankles, shins
Hypertrophic Thick, verrucous, intensely pruritic plaques Shins/ankles; chronic; risk of SCC
Annular Ring-shaped with central clearing Glans penis, axillae
Atrophic Few atrophic lesions, white-blue hue Resolved hypertrophic lesions
Follicular (LP pilaris) Keratotic follicular papules → scarring alopecia Scalp; Graham-Little syndrome
Bullous / LP pemphigoides Vesicles over LP lesions; BP180 antibodies Lower limbs
Actinic Annular hyperpigmented plaques Sun-exposed areas; tropics, darker skin
Linear Lesions along Blaschko lines Children; Koebner-related
Pigmentosus Diffuse grey-brown macules Face/flexures; Indians, common in exams
Lichen planopilaris Perifollicular erythema + scarring alopecia Scalp

High-yield: The classic LP lesion is described by the six PsPurple (violaceous), Polygonal, Planar (flat-topped), Pruritic, Papules, with Plaques. Add a seventh P for Pterygium (nails).

Etiology & pathophysiology

LP is idiopathic but driven by a T-cell autoimmune mechanism. The current model:

Antigen alteration in basal keratinocytes → presentation to CD8+ cytotoxic T cells → keratinocyte apoptosis → basal layer destruction → reactive epidermal changes.

Key immunological and associated factors:

  • CD8+ cytotoxic T lymphocytes are the principal effectors; CD4+ cells assist. Apoptosis is mediated via Fas–FasL and granzyme/perforin pathways.
  • Hepatitis C virus (HCV) — the most exam-tested association, especially with oral LP and in Mediterranean/Asian populations. Screen for HCV in widespread or oral LP.
  • Drug-induced LP (lichenoid drug eruption): remember the mnemonic — "GOLD ACT-B" style list — Gold, Oral hypoglycaemics, beta-blockers, Antimalarials (hydroxychloroquine, quinine), Captopril/ACE inhibitors, Thiazides, NSAIDs, penicillamine, and antimalarials. Lichenoid drug eruptions are often photodistributed, more eczematous, and lack Wickham striae.
  • Contact LP: dental amalgam (mercury) causing oral lichenoid lesions adjacent to fillings; colour-film developers (para-phenylenediamine).
  • Graft-versus-host disease produces lichenoid lesions histologically identical to LP.
  • Associations: autoimmune diseases (alopecia areata, vitiligo, myasthenia gravis, ulcerative colitis, primary biliary cholangitis), dyslipidaemia, and possibly diabetes.

High-yield: Hepatitis C association is strongest for oral lichen planus. Always think HCV serology in an exam vignette of erosive/reticulate oral LP.

Clinical features

Skin

  • Symmetrical, violaceous, shiny, flat-topped polygonal papules with fine white lacy lines (Wickham striae) on the surface, best seen after applying oil/mineral oil or on dermoscopy.
  • Favoured sites: flexor surfaces of wrists and forearms, ankles, shins, lower back, genitalia.
  • Intensely pruritic — yet patients characteristically rub rather than scratch, so excoriations are uncommon.
  • Koebner phenomenon (isomorphic response): new lesions appear in lines of trauma/scratching — shared with psoriasis, vitiligo, warts.
  • Resolves with characteristic post-inflammatory hyperpigmentation, prominent in Indian skin.

Mucosal LP

  • Affects ~50% of cutaneous LP patients; may occur in isolation.
  • Buccal mucosa is the commonest site; presents as a lacy, reticulate white network (Wickham striae) — the reticular form is most common and asymptomatic.
  • Erosive/atrophic form is painful, persistent, and carries the malignant potential.
  • Genital mucosa: vulvovaginal-gingival syndrome (erosive LP of vulva, vagina, gingiva) and peno-gingival syndrome in males.

Nail LP (~10%)

  • Longitudinal ridging, thinning, fissuring, and the hallmark pterygium formation (dorsal pterygium = scarring overgrowth of proximal nail fold onto the nail bed).
  • Twenty-nail dystrophy (trachyonychia) can be a presentation, especially in children.
  • Anonychia = complete and permanent nail loss in severe cases.

Hair / scalp

  • Lichen planopilaris → perifollicular erythema, follicular hyperkeratosis, and scarring (cicatricial) alopecia.
  • Graham-Little-Piccardi-Lassueur syndrome: triad of scarring scalp alopecia + non-scarring axillary/pubic hair loss + follicular keratotic papules on body.

High-yield: Wickham striae (lacy white lines) on the papule surface and on buccal mucosa are pathognomonic. Pterygium of the nail and scarring alopecia indicate permanent damage.

Diagnosis & investigation of choice

Diagnosis is usually clinical, supported by skin biopsy (histopathology) — the investigation of choice.

Diagnostic approach:

  1. Identify the six Ps + Wickham striae clinically (use dermoscopy/oil immersion).
  2. Examine mucosa, nails, scalp, genitalia for occult involvement.
  3. Biopsy ambiguous, hypertrophic, erosive, or non-resolving lesions.
  4. Screen for hepatitis C (anti-HCV) in oral/extensive disease.
  5. Direct immunofluorescence (DIF) if bullous or to exclude autoimmune blistering disease.
  6. Review drug history to exclude lichenoid drug eruption.

Histopathology — classic findings

Feature Description
Hyperkeratosis Orthokeratosis (without parakeratosis — unlike psoriasis)
Granular layer Wedge-shaped hypergranulosis (corresponds to Wickham striae)
Epidermal pattern Irregular acanthosis → "saw-tooth" rete ridges
Basal layer Liquefactive (vacuolar) degeneration of the basal cell layer
Dermo-epidermal junction Band-like (lichenoid) lymphocytic infiltrate hugging the junction
Apoptotic keratinocytes Civatte / colloid / hyaline bodies (apoptotic keratinocytes)
Clefting Max-Joseph spaces (subepidermal clefts from basal damage)

Direct immunofluorescence: shaggy fibrinogen deposition along the basement membrane zone and globular IgM deposits on colloid bodies.

High-yield mnemonic for histology — "HHIVB" / remember the buzzwords: Hyperkeratosis (ortho), Hypergranulosis (wedge), Irregular acanthosis (saw-tooth rete pegs), Vacuolar basal degeneration, Band-like infiltrate, plus Civatte bodies and Max-Joseph spaces.

Management / drug of choice

LP is self-limiting in many cutaneous cases (often resolving within 1–2 years) but mucosal and hypertrophic disease is chronic.

Stepwise management:

First line → potent/super-potent topical corticosteroids (clobetasol propionate 0.05%, betamethasone) → topical calcineurin inhibitors (tacrolimus/pimecrolimus, especially for mucosal/genital LP) → intralesional triamcinolone for hypertrophic plaques and nails → systemic corticosteroids or phototherapy for widespread disease → oral retinoids / methotrexate / mycophenolate for refractory disease.

Scenario Drug of choice
Localised cutaneous LP Potent topical corticosteroid (clobetasol)
Hypertrophic LP Intralesional triamcinolone ± occlusion
Widespread/eruptive LP Systemic corticosteroids (short course) or NB-UVB phototherapy
Oral reticular LP (asymptomatic) Reassurance + oral hygiene; no treatment
Erosive oral/genital LP Topical corticosteroid (in orabase) ± topical tacrolimus
Lichen planopilaris Potent topical/intralesional steroid; oral hydroxychloroquine
Refractory/severe Acitretin, methotrexate, mycophenolate, ciclosporin
Nail LP Intralesional or systemic corticosteroids (to prevent pterygium)

Supportive: antihistamines for pruritus; sun protection in actinic LP; stop the offending drug in lichenoid drug eruption; replace amalgam fillings in contact-induced oral LP.

High-yield: Drug of choice for typical cutaneous LP = potent topical corticosteroids. For erosive oral LP unresponsive to steroids, topical tacrolimus is preferred. NB-UVB/PUVA is used for extensive disease.

Complications

  • Malignant transformation: Erosive/atrophic oral LP can progress to oral squamous cell carcinoma (overall risk ~1%); the WHO classifies oral LP as a potentially malignant disorder. Hypertrophic LP of the legs can also undergo SCC change in long-standing lesions. → Mandates long-term follow-up and biopsy of suspicious areas.
  • Scarring sequelae: cicatricial alopecia (lichen planopilaris), nail pterygium/anonychia, oesophageal/vaginal strictures from erosive mucosal LP.
  • Post-inflammatory hyperpigmentation — cosmetically significant, especially in Indian/darker skin.
  • Psychological morbidity from chronic pruritus and visible lesions.

High-yield: Oral erosive LP is a premalignant condition → squamous cell carcinoma. This is one of the single most repeated facts in NEET PG dermatology.

Key differentials

Condition Distinguishing point from LP
Psoriasis Silvery scale, Auspitz sign, parakeratosis + Munro microabscess histology; extensor surfaces
Lichenoid drug eruption Photodistributed, eczematous, parakeratosis + eosinophils on biopsy, no Wickham striae; drug history
Pityriasis rosea Herald patch, Christmas-tree distribution on trunk, self-limiting in weeks
Lichen nitidus Tiny pinhead skin-coloured papules; "ball-in-claw" histology; grouped on penis/forearms
Lichen sclerosus Porcelain-white atrophic plaques, anogenital, figure-of-eight distribution
Discoid lupus erythematosus Follicular plugging, scarring, photodistribution; oral LE on palate
Secondary syphilis Copper-coloured papules on palms/soles, serology positive, mucous patches
Leukoplakia (oral) Homogeneous white plaque, cannot be rubbed off, no reticulate pattern
Graft-versus-host disease Identical lichenoid histology; transplant context

High-yield: Lichen nitidus — multiple tiny, shiny, flesh-coloured papules; histology shows a focal lymphohistiocytic infiltrate clutched by elongated rete ridges ("claw clutching a ball"). Frequently paired with LP in MCQs.

Comparison with psoriasis (frequently paired)

Feature Lichen planus Psoriasis
Colour Violaceous Salmon-pink/red
Scale Minimal, adherent Silvery, loose
Distribution Flexor (wrists, ankles) Extensor (elbows, knees)
Surface Wickham striae Auspitz sign
Keratin Orthokeratosis Parakeratosis
Granular layer Hypergranulosis (wedge) Absent/diminished granular layer
Infiltrate Band-like (lichenoid) Munro microabscesses (neutrophils)
Koebner Positive Positive
Nails Pterygium, ridging Pitting, oil-drop, onycholysis

Recently asked / exam angle

  • Six Ps identification from a clinical photo of violaceous flat-topped papules on the wrist — classic image-based MCQ.
  • Wickham striae — definition, where seen (papule surface + buccal mucosa), and its histological correlate (wedge-shaped hypergranulosis).
  • Histology buzzwords: saw-tooth rete ridges, band-like lymphocytic infiltrate, Civatte (colloid) bodies, Max-Joseph spaces, orthohyperkeratosis — and contrast with parakeratosis of psoriasis.
  • Hepatitis C as the systemic association of (oral) LP.
  • Oral erosive LP → squamous cell carcinoma (potentially malignant disorder).
  • Nail pterygium as a sign of LP; twenty-nail dystrophy in children.
  • Graham-Little syndrome triad and lichen planopilaris as a cause of scarring alopecia.
  • Lichenoid drug eruption drug list (beta-blockers, antimalarials, thiazides, ACE inhibitors, gold, NSAIDs).
  • Drug of choice = potent topical corticosteroid; tacrolimus for resistant oral LP.
  • Differentiating lichen nitidus ("claw clutching a ball") from LP.
  • DIF findings: shaggy fibrinogen at the BMZ, IgM on colloid bodies.

Rapid revision

  1. Six Ps: Purple, Polygonal, Planar (flat-topped), Pruritic Papules/Plaques — add Pterygium (nail).
  2. Wickham striae = lacy white lines on papules/buccal mucosa; histological correlate = wedge hypergranulosis.
  3. Sites: flexor wrists, ankles, shins; oral LP commonest on buccal mucosa.
  4. Mediated by CD8+ cytotoxic T cells against basal keratinocytes.
  5. Strongest systemic association = hepatitis C (esp. oral LP).
  6. Histology: orthokeratosis, hypergranulosis, saw-tooth rete ridges, basal vacuolar degeneration, band-like infiltrate, Civatte bodies, Max-Joseph spaces.
  7. DIF: shaggy fibrinogen at BMZ + IgM on colloid bodies.
  8. Erosive oral LP → squamous cell carcinoma (potentially malignant disorder).
  9. Nail signs: pterygium, longitudinal ridging, trachyonychia, anonychia.
  10. Scalp: lichen planopilaris → scarring alopecia; Graham-Little syndrome triad.
  11. Drug of choice = potent topical corticosteroid; tacrolimus for resistant oral/genital LP; NB-UVB/PUVA for extensive disease.
  12. Lichen nitidus = tiny papules, "claw clutching a ball" histology — classic LP differential.